Envision Strengthens Financial Position With Successful Repricing and Partial Pay-Down of First Lien Term Loan

NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare (“Envision”) today announced the successful repricing of its First Lien Term Loan, securing more favorable terms and partially paying down principal of the facility. This important milestone further strengthens Envision’s long-term financial stability and its ongoing ability to invest in clinicians and support the delivery of high-quality care.

With a strong credit profile and a more efficient capital structure, Envision is focused on its future. The organization continues to benefit from lower leverage, lower interest costs, increased liquidity, greater financial flexibility and no near-term refinancing obligations.

“This transaction represents another meaningful step forward as we advance our long-term strategy and initiatives to deliver sustained value for our teams, partners and communities,” said Jason Owen, President and Chief Executive Officer of Envision. “We are building a stronger organization that is well-positioned to continue protecting and uplifting clinicians in an ever-changing healthcare landscape.”

As part of the transaction, Envision decreased its Term Loan balance from $275 million to $200 million, significantly reducing its balance sheet risk and decreasing its total debt from $363 million to $288 million.

The repricing follows Envision’s proactive completion of two significant financing transactions in 2025: a new Term Loan and a new Asset-Based Lending (ABL) Revolving Credit Facility, which strengthened Envision’s balance sheet.

About Envision Healthcare

Envision Healthcare is a leading medical group that delivers physician and advanced practice provider services, primarily in the areas of emergency and hospitalist medicine and anesthesiology. Envision’s medical group offers a differentiated suite of clinical solutions on a national scale with a local understanding of our communities, creating value for health systems, payers, providers and patients. For additional information, visit www.envisionhealth.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain forward-looking statements (all statements other than with respect to historical fact) within the meaning of the federal securities laws, which are intended to be covered by the safe harbors created thereby. Lenders and stockholders are cautioned that all forward-looking statements involve known and unknown risks and uncertainties including, without limitation, Envision’s ability to comply with the covenants in its term loan agreement and ABL facility and to use the proceeds thereof to advance its long-term strategy and initiatives. Although Envision believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate. Therefore, there can be no assurance that the forward-looking statements included herein will prove to be accurate. Actual results could differ materially and adversely from those contemplated by any forward-looking statement. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Envision or any other person that Envision’s objectives and plans will be achieved. Envision undertakes no obligation to release any revisions to any forward-looking statements to reflect events and circumstances occurring after the date hereof or to reflect unanticipated events.

Contacts

[e-mail]
[e-mail]
www.EnvisionHealth.com